Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatments & Surgery
Share your love
MediPrint Announces Positive Results for Glaucoma Lens
MediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a 3D-printed, drug-eluting contact lens designed to treat mild to moderate glaucoma. These results, presented by Ian Ben Gaddie, OD, FAAO, at the American Academy of…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…
Tarsus Appoints Dr. Elizabeth Yeu as Chief Medical Officer
Tarsus Pharmaceuticals has announced the appointment of Elizabeth Yeu, MD, as Chief Medical Officer, effective November 4, 2024. Dr. Yeu, an esteemed ophthalmologist with over two decades of clinical and leadership experience, will lead the company’s medical organization and oversee…
Formosa: Positive Phase 3 Results for APP13007 in China
Formosa Pharmaceuticals recently announced the completion of CPN-303, a Phase 3 clinical trial conducted in Chinese cataract surgery patients to evaluate APP13007 (GPN00833). This trial, managed by Formosa’s licensee Grand Pharma (0512.HK), demonstrated positive top-line results, showcasing APP13007’s effectiveness in…
VSY Biotechnology Unveils Maestro® Sinusoidal IOL at ESCRS24
VSY Biotechnology to Complete Global Rollout of its Sinusoidal Vision Technology (SVT®) at ESCRS 2024 This year’s European Society of Cataract and Refractive Surgeons (ESCRS) 2024 kicked off with the highly anticipated third iNovation Day, which brought together the medical…
ChatGPT-4o Shows Promise in Addressing Retinal Diseases
A recent study highlights the potential of ChatGPT-4o in accurately answering questions related to retinal diseases, covering diagnostic criteria, treatment guidelines, and management strategies. The AI’s performance was evaluated by vitreoretinal specialists, focusing on its alignment with the American Academy of…
How Smoking Affects Your Eye Health
Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, and stroke. However, the harmful effects of smoking extend beyond these well-known conditions, significantly impacting eye health as well.…
Calcium Channel Blockers Increase Risk of Glaucoma
A comprehensive meta-analysis revealed that the use of calcium channel blockers (CCBs), particularly cardioselective agents, was associated with a modest but statistically significant risk of glaucoma. The analysis indicated that patients with a prior history of CCB treatment had a…
What Is Suprachoroidal Hemorrhage? | OBN
What Is Suprachoroidal Hemorrhage? Suprachoroidal hemorrhage is a sight-destroying pathology. It arises when there is a rupture of long or short ciliary arteries during an intraocular surgery and blood is contained in the space between the choroid and the sclera.…
Peters Anomaly: Causes, Symptoms and Management
What Is Peters Anomaly? Peters anomaly is a rare congenital ocular condition primarily affecting the anterior segment of the eye. At its core, it’s characterized by the abnormal development of the cornea’s central layers and potential adhesions between the cornea…